Independent and joint effects of vascular and cardiometabolic risk factor pairs for risk of all-cause dementia: a prospective population-based study

Int Psychogeriatr. 2019 Oct;31(10):1421-1432. doi: 10.1017/S1041610219001066.

Abstract

Objectives: To assess independent and joint effects of pairs of vascular and cardiometabolic risk factors (VCMRFs) in relation to risk of all-cause dementia.

Design: Population-based longitudinal cohort study of cognitive impairment. We used an algorithm to select pairs of VCMRFs and tested their joint effects in time-dependent Cox models. We used attributable proportions (AP) to measure the proportion of risk from interactions beyond any additive effect.

Setting: Economically depressed small-town population.

Participants: Adults age 65+ years with up to 10 yearly study visits (N=1701, median (Q1, Q3) age, 78 (71.0, 83.0), 62.3% female, 94.9% white).

Results: Among 1701 participants free from prevalent dementia with at least one follow-up visit, 109 developed incident all-cause dementia. In pairings of APOE*4 with hypertension (HTN) and congestive heart failure (CHF), the variables contributed independently and additively to all-cause dementia risk. In pairings of APOE*4 with stroke and stroke with CHF, the variables demonstrated independent contributions to all-cause dementia risk; their joint effects showed excess detriment demonstrating synergistic interactions (joint HR [95% CI]: 28.33 [6.74, 119.01] and 50.30 [14.57, 173.57] respectively, fully adjusted models). Physical activity (PA) was independently associated with lower all-cause dementia risk when paired with APOE*4, stroke, and CHF in unadjusted models; these associations did not survive covariate adjustment. The joint effect of low PA and APOE*4 was associated with additively increased all-cause dementia risk (joint HR [95% CI]: 4.61 [2.07, 10.23], fully adjusted model).

Conclusions: Reduction of VCMRFs, including low PA, could be valuable for dementia prevention, especially among APOE*4 carriers.

Keywords: Alzheimer‘s disease (AD); apolipoprotein E (APOE); cerebral vascular disease (CVD); dementia; epidemiology.

Publication types

  • Observational Study
  • Research Support, N.I.H., Extramural

MeSH terms

  • Aged
  • Aged, 80 and over
  • Aging
  • Apolipoprotein E4 / genetics
  • Cognitive Dysfunction / complications*
  • Cognitive Dysfunction / epidemiology
  • Dementia / epidemiology*
  • Dementia / genetics
  • Exercise
  • Female
  • Heart Failure / complications*
  • Heart Failure / epidemiology
  • Heterozygote
  • Humans
  • Hypertension / complications*
  • Hypertension / epidemiology
  • Male
  • Pennsylvania / epidemiology
  • Proportional Hazards Models
  • Prospective Studies
  • Risk Factors
  • Stroke / complications*
  • Stroke / epidemiology

Substances

  • Apolipoprotein E4